Recurrence pattern after concomitant radio-chemotherapy in newly diagnosed glioblastoma patients: Correlation with MGMT promoter methylation status

Authors :: V. Mazzocchi
Stefania Bartolini
V. Blatt
Aa Brandes
Alicia Tosoni
F. Benevento
Enrico Franceschi
L. Scopece
F. Ruggeri
Luca Morandi
Source :: Journal of Clinical Oncology. 26:2027-2027
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 2027 Background: Temozolomide (TMZ), concomitant with and adjuvant to radiotherapy (RT), has become the standard treatment for newly diagnosed glioblastoma (GBM). The aim of the present analysis wa...

Tools